Gufic Biosciences · NSE: GUFICBIO · BSE: 509079
Q3 FY19 results · Oct–Dec 2018
Gufic Biosciences reported revenue from operations of ₹87.65 crore and net profit of ₹5.88 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 87.65 | — | — | 92.42 | −5.2% |
| Other income | 0.23 | — | — | 0.70 | −67.7% |
| Total income | 87.88 | — | — | 93.12 | −5.6% |
| Profit before tax | 8.79 | — | — | 9.52 | −7.7% |
| Net profit for the period | 5.88 | — | — | 6.19 | −5.0% |
| EPS, basic (₹) | 0.76 | — | — | 0.79 | −3.8% |
| Net margin (%) | 6.7 | — | 6.7 |
Standalone
- Filed with BSE
- 14 Feb 2019, 12:02 IST
- Board meeting
- 13 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE